Advertisement

Supplier's News

Inalve raises €2 million to accelerate biofilm-based microalgae production

The French company has developed a proprietary process for cultivating microalgae on rotating conveyors, using minimal water, maximizing light exposure, and reducing contribution to climate change.

invalve_Photo11
Credits: Inalve
December 14, 2023

Inalve, a leader in biofilm-based production of microalgae, successfully closed a EUR 2 million financing round by Seventure Partners’ Blue Forward Fund™ (France). Existing investors including Kreaxi and Angelor also participated.

Inalve, established in Nice, France, has developed a unique proprietary process for cultivating microalgae on rotating conveyors, using minimal water, maximizing light exposure, and reducing contribution to climate change compared to traditional cultivation systems. The company aims to build a high-performance microalgae industry that balances economic, environmental, and social impacts.

“We are thrilled by Blue Forward fund™’s investment in Inalve. This partnership, rooted in shared values and ambitions for the planet and its people, marks a significant milestone in Inalve’s journey. It provides substantial support for our future growth, both financially and operationally, and instills trust in our company. We are embarking on a long-term partnership that will accelerate and amplify our impact, said Véronique Raoul, CEO of Inalve. “Thanks to our innovative process, our goal is to produce large volumes of microalgae with consistent quality, enhanced nutritional characteristics, continuous supply, competitive prices and, at the same time, significantly reduce the environmental footprint of microalgae production.”

Inalve’s innovative process cultivates microalgae while preserving natural resources and enables the cost-effective commercialization of a unique product: live microalgae in concentrated form, rich in health ingredients. This not only improves the productivity of hatcheries in aquaculture but also simplifies logistics, enhances biosecurity of aquaculture farms and guarantee respect for the natural food chain for consumers.

Isabelle de Cremoux, CEO & managing partner of Seventure Partners, said that “in aquaculture, mass production of larvae and juveniles in good nutritional and health conditions is one of the most important factors to ensure success. As a pioneer in the commercialization of live microalgae, we believe Inalve is perfectly positioned to support the aquaculture transition and provide a sustainable protein source while preserving our ocean ecosystems. We are delighted to support Inalve’s management in its journey to enhance aquacultural performances.”